Rare respiratory diseases are ready for primetime: from Rare Disease Day to the European Reference Networks
暂无分享,去创建一个
[1] M. Eyries,et al. Genetic analyses in a cohort of children with pulmonary hypertension , 2016, European Respiratory Journal.
[2] J. Moss,et al. The changing face of a rare disease: lymphangioleiomyomatosis , 2015, European Respiratory Journal.
[3] C. Kuehni,et al. Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis , 2016, European Respiratory Journal.
[4] R. Epaud,et al. Management of children with interstitial lung diseases: the difficult issue of acute exacerbations , 2016, European Respiratory Journal.
[5] H. Collard,et al. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm , 2015, European Respiratory Journal.
[6] Stefano Aliberti,et al. Management of bronchiectasis in adults , 2015, European Respiratory Journal.
[7] V. Vorselaars,et al. Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia , 2016, European Respiratory Journal.
[8] E. Roach,et al. Tuberous sclerosis complex. , 2015, Handbook of clinical neurology.
[9] M. Frydenberg,et al. Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders , 2016, European Respiratory Journal.
[10] J. Ryu. Faculty of 1000 evaluation for An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. , 2016 .
[11] M. Humbert,et al. Toward better management of rare and orphan pulmonary diseases , 2016, European Respiratory Journal.
[12] K. Batra,et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive , 2016, European Respiratory Journal.
[13] J. Chalmers,et al. Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration , 2016, European Respiratory Journal.
[14] J. Pépin,et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep , 2017, European Respiratory Journal.
[15] P. Burgel,et al. Future trends in cystic fibrosis demography in 34 European countries , 2015, European Respiratory Journal.
[16] M. Humbert,et al. Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.
[17] G. Canonica,et al. Public awareness on cystic fibrosis: results from a national pragmatic survey , 2015, European Respiratory Journal.
[18] M. Humbert,et al. Genetic counselling in a national referral centre for pulmonary hypertension , 2015, European Respiratory Journal.
[19] M. Humbert,et al. Rare (pulmonary) disease day: “feeding the breath, energy for life!” , 2015, European Respiratory Journal.
[20] Simon Gibbs,et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.
[21] P. Lackie,et al. Accuracy of diagnostic testing in primary ciliary dyskinesia , 2015, European Respiratory Journal.
[22] N. Kamel. European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive? , 2016, European Respiratory Journal.
[23] D. Maucort-Boulch,et al. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis , 2016, European Respiratory Journal.
[24] R. Slama,et al. Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study , 2017, European Respiratory Journal.
[25] D. Sengupta,et al. Congenital diaphragmatic hernia. , 1963, The Indian journal of child health.
[26] M. Humbert,et al. Pulmonary arterial hypertension in patients treated with interferon , 2014, European Respiratory Journal.
[27] M. Humbert,et al. BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension , 2016, European Respiratory Journal.
[28] Thierry Troosters,et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.
[29] H. Collard,et al. Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to? , 2015, European Respiratory Review.
[30] T. Greulich,et al. The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database , 2017, European Respiratory Journal.
[31] A. Quittner,et al. A quality-of-life measure for adults with primary ciliary dyskinesia: QOL–PCD , 2015, European Respiratory Journal.
[32] Jianhua Yao,et al. Severity and outcome of cystic lung disease in women with tuberous sclerosis complex , 2015, European Respiratory Journal.
[33] G. Verleden,et al. An association of particulate air pollution and traffic exposure with mortality after lung transplantation in Europe , 2017, European Respiratory Journal.
[34] T. Welte,et al. Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis , 2015, European Respiratory Journal.
[35] L. Behan,et al. Diagnosing primary ciliary dyskinesia: an international patient perspective , 2016, European Respiratory Journal.
[36] G. Sotgiu,et al. Clinical phenotypes in adult patients with bronchiectasis , 2016, European Respiratory Journal.
[37] A. Nicholson,et al. Nonspecific interstitial pneumonia: survival is influenced by the underlying cause , 2014, European Respiratory Journal.
[38] Y. Cozier. Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions , 2016, European Respiratory Journal.
[39] D. Lynch,et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.
[40] H. Omran,et al. An international registry for primary ciliary dyskinesia , 2015, European Respiratory Journal.
[41] D. Gossot,et al. Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis , 2016, European Respiratory Journal.
[42] G. Verleden,et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome , 2014, European Respiratory Journal.
[43] J. Grunewald,et al. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden , 2016, European Respiratory Journal.
[44] T. Welte,et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry , 2015, European Respiratory Journal.
[45] W. Wuyts,et al. European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers , 2015, European Respiratory Journal.
[46] J. Sundquist,et al. Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study , 2016, European Respiratory Journal.
[47] H. Omran,et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia , 2017, European Respiratory Journal.
[48] T. Fingerlin,et al. Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis , 2016, European Respiratory Journal.
[49] G. Koch,et al. A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials , 2015, European Respiratory Journal.
[50] G. A. Whitmore,et al. A contemporary survival analysis of individuals with cystic fibrosis: a cohort study , 2014, European Respiratory Journal.
[51] P. Revy,et al. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis , 2016, European Respiratory Journal.
[52] M. Humbert,et al. Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) , 2016, European Respiratory Journal.